Glomerular Disease Updates From ASN 2023 Glomerular Disease Updates From ASN 2023

Updates on glomerular diseases from ASN 2023 include data from the NeflgArd trial examining Nefecon for immunoglobulin A nephropathy and the benefits of sparsentan as reported by two trials.Medscape

Source: Medscape Today Headlines - November 22, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news